| Dr Alicia J Schade, MD | |
|
326 Washington St, Norwich, CT 06360-2740 | |
| (860) 889-8331 | |
| Not Available |
| Full Name | Dr Alicia J Schade |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 24 Years |
| Location | 326 Washington St, Norwich, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720020514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 049013 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| William W Backus Hospital | Norwich, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North American Partners In Anesthesia Connecticut Pc | 6709877939 | 45 |
News Archive
Previous standards of cancer follow-up care and support may no longer meet current needs as improvements in screening practices, early diagnosis and treatment of cancer have put long-term survival beyond five years following diagnosis within reach for more than half of patients in Europe.
AVEO Pharmaceuticals, Inc. today announced that the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee, has approved the use of the nonproprietary generic name "ficlatuzumab" (pronounced fye" kla tue' zue mab) for AV-299, a potent, functional anti-HGF/c-MET antibody internally discovered at AVEO.
One way obese people become salt sensitive and hypertensive has been identified by Medical College of Georgia researchers.
A natural mechanism by which our cells kill the bacterium responsible for tuberculosis (TB) has been discovered by scientists at the Francis Crick Institute, which could help in the battle against antibiotic-resistant bacteria.
GfK HealthCare, one the largest providers of fully integrated custom health care marketing research in the world, announced today the undertaking of a first-ever research study aimed at examining the UK's National Institute for Health and Clinical Excellence as a model producer of Health Technology Appraisals, and its impact on decision making in ex-UK health care systems.
› Verified 8 days ago
| Entity Name | Integrated Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636397 PECOS PAC ID: 1759281165 Enrollment ID: O20040112000163 |
News Archive
Previous standards of cancer follow-up care and support may no longer meet current needs as improvements in screening practices, early diagnosis and treatment of cancer have put long-term survival beyond five years following diagnosis within reach for more than half of patients in Europe.
AVEO Pharmaceuticals, Inc. today announced that the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee, has approved the use of the nonproprietary generic name "ficlatuzumab" (pronounced fye" kla tue' zue mab) for AV-299, a potent, functional anti-HGF/c-MET antibody internally discovered at AVEO.
One way obese people become salt sensitive and hypertensive has been identified by Medical College of Georgia researchers.
A natural mechanism by which our cells kill the bacterium responsible for tuberculosis (TB) has been discovered by scientists at the Francis Crick Institute, which could help in the battle against antibiotic-resistant bacteria.
GfK HealthCare, one the largest providers of fully integrated custom health care marketing research in the world, announced today the undertaking of a first-ever research study aimed at examining the UK's National Institute for Health and Clinical Excellence as a model producer of Health Technology Appraisals, and its impact on decision making in ex-UK health care systems.
› Verified 8 days ago
| Entity Name | North American Partners In Anesthesia Connecticut Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316994775 PECOS PAC ID: 6709877939 Enrollment ID: O20040519000120 |
News Archive
Previous standards of cancer follow-up care and support may no longer meet current needs as improvements in screening practices, early diagnosis and treatment of cancer have put long-term survival beyond five years following diagnosis within reach for more than half of patients in Europe.
AVEO Pharmaceuticals, Inc. today announced that the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee, has approved the use of the nonproprietary generic name "ficlatuzumab" (pronounced fye" kla tue' zue mab) for AV-299, a potent, functional anti-HGF/c-MET antibody internally discovered at AVEO.
One way obese people become salt sensitive and hypertensive has been identified by Medical College of Georgia researchers.
A natural mechanism by which our cells kill the bacterium responsible for tuberculosis (TB) has been discovered by scientists at the Francis Crick Institute, which could help in the battle against antibiotic-resistant bacteria.
GfK HealthCare, one the largest providers of fully integrated custom health care marketing research in the world, announced today the undertaking of a first-ever research study aimed at examining the UK's National Institute for Health and Clinical Excellence as a model producer of Health Technology Appraisals, and its impact on decision making in ex-UK health care systems.
› Verified 8 days ago
| Entity Name | Connecticut Gi Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023124625 PECOS PAC ID: 9830110758 Enrollment ID: O20070112000011 |
News Archive
Previous standards of cancer follow-up care and support may no longer meet current needs as improvements in screening practices, early diagnosis and treatment of cancer have put long-term survival beyond five years following diagnosis within reach for more than half of patients in Europe.
AVEO Pharmaceuticals, Inc. today announced that the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee, has approved the use of the nonproprietary generic name "ficlatuzumab" (pronounced fye" kla tue' zue mab) for AV-299, a potent, functional anti-HGF/c-MET antibody internally discovered at AVEO.
One way obese people become salt sensitive and hypertensive has been identified by Medical College of Georgia researchers.
A natural mechanism by which our cells kill the bacterium responsible for tuberculosis (TB) has been discovered by scientists at the Francis Crick Institute, which could help in the battle against antibiotic-resistant bacteria.
GfK HealthCare, one the largest providers of fully integrated custom health care marketing research in the world, announced today the undertaking of a first-ever research study aimed at examining the UK's National Institute for Health and Clinical Excellence as a model producer of Health Technology Appraisals, and its impact on decision making in ex-UK health care systems.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alicia J Schade, MD 11781 Lee Jackson Memorial Hwy, Ste 550, Fairfax, VA 22033-3309 Ph: (571) 777-5164 | Dr Alicia J Schade, MD 326 Washington St, Norwich, CT 06360-2740 Ph: (860) 889-8331 |
News Archive
Previous standards of cancer follow-up care and support may no longer meet current needs as improvements in screening practices, early diagnosis and treatment of cancer have put long-term survival beyond five years following diagnosis within reach for more than half of patients in Europe.
AVEO Pharmaceuticals, Inc. today announced that the United States Adopted Names (USAN) Council, in consultation with the World Health Organization (WHO) International Nonproprietary Names Expert Committee, has approved the use of the nonproprietary generic name "ficlatuzumab" (pronounced fye" kla tue' zue mab) for AV-299, a potent, functional anti-HGF/c-MET antibody internally discovered at AVEO.
One way obese people become salt sensitive and hypertensive has been identified by Medical College of Georgia researchers.
A natural mechanism by which our cells kill the bacterium responsible for tuberculosis (TB) has been discovered by scientists at the Francis Crick Institute, which could help in the battle against antibiotic-resistant bacteria.
GfK HealthCare, one the largest providers of fully integrated custom health care marketing research in the world, announced today the undertaking of a first-ever research study aimed at examining the UK's National Institute for Health and Clinical Excellence as a model producer of Health Technology Appraisals, and its impact on decision making in ex-UK health care systems.
› Verified 8 days ago
Dr. Jeremy Gordon Burke, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, Department Of Anesthesiology, Norwich, CT 06360 Phone: 860-889-8331 | |
Adam Drew Goldstein, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331 | |
Daniel Hseuh, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331 | |
Dr. William L Thompson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331 | |
Dr. John Paggioli, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 190 W Town St, Norwich, CT 06360 Phone: 860-885-0333 Fax: 860-885-1319 | |
Dr. Robert Lewis Ringering, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331 |